Secretome Therapeutics

Dallas, United States

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

May 2026

Series A

Biotechnology Health Care Medical Therapeutics

Top Investors

RA Capital ManagementTEDCOUniversity System of Maryland Momentum FundParent Project Muscular DystrophyHEST

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Secretome Therapeutics

Who are Secretome Therapeutics's investors?

Secretome Therapeutics's investors include RA Capital Management, TEDCO, University System of Maryland Momentum Fund, Parent Project Muscular Dystrophy, HEST.

Where is Secretome Therapeutics headquartered?

Secretome Therapeutics is headquartered in Dallas, United States.

What does Secretome Therapeutics do?

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

What stage is Secretome Therapeutics at?

Secretome Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2026.

MLA

"Secretome Therapeutics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/secretome-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Secretome Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/secretome-therapeutics

Wikipedia (cite web)

{{cite web |title=Secretome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/secretome-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2026.